BNGO - Bionano Genomics Inc. (BNGO) CEO Erik Holmlin at 2nd Annual Maxim Group Virtual Growth Conference (Transcript)

Bionano Genomics, Inc. (BNGO) 2nd Annual Maxim Group Virtual Growth Conference March 30, 2022, 03:30 PM ET Company Participants Erik Holmlin - Chief Executive Officer Michael Paul - Chief Strategy Officer Conference Call Participants Jason McCarthy - Biotechnology Analyst at Maxim Group Presentation Jason McCarthy Welcome back everyone. Today we are bringing you Erik Holmlin, the CEO of Bionano Genomics. Bionano’s developing Optical Genome Mapping or OGM which is a genomic interrogation technique that provides long range structural information you can access with other techniques. The last few years have been focussed on generating the publications, build the awareness and demonstrating the clinical utility with their Saphyr system to be able to replace laborious manual cytogenetic techniques and to complement sequencing for a more complete interrogation of the Genome. Now the Bionano story is evolving with a greater focus on refining the platform, software and strategy to drive its growing

For further details see:

Bionano Genomics, Inc. (BNGO) CEO Erik Holmlin at 2nd Annual Maxim Group Virtual Growth Conference (Transcript)